Mood in the global markets was sombre on rising coincerns over the new strain in coronavirus in the UK, and after President Donald Trump to call the newly passed $900-billion coronavirus aid package “a disgrace” and demanding that lawmakers more than triple relief payments to Americans.
That said, investors might get some solace from a Reuters report that said India is likely to approve Oxford/AstraZeneca’s coronavirus vaccine for emergency use by next week after its local manufacturer submitted additional data sought by authorities
In overnight deals, US stocks ended mostly lower over concerns the new Covid-19 variation could further hamper a softening economic recovery even though the World Health Organisation has said the new variant is not out of control yet.
Overall, the S&P 500 ended down 0.21 per cent and the Dow fell 0.67 per cent, while the Nasdaq gained half a per cent.
(With inputs from Reuters)